ConforMIS closes a $168 million funding round for its personalized implant technology.
ConforMIS closed a Series E round worth $167.7 million, raised from a consortium of 88 unnamed investors, according to regulatory filings.
The Bedford, Mass.-based medical device company makes personalized knee implants based on scans detailing patients’ physiology, creating customized instruments and implants that are shipped in a sterile package surgeons can open on the operating table.
Reached by MassDevice.com today, CEO Philipp Lang declined to comment on the company’s latest funding round.
ConforMIS said it plans to use the cash for “working capital and potential business transactions,” according to the filings.
In May the company lured former Zimmer executive Matthew Scott to be its new COO as it scales up its knee implant business.